CLINICAL_TRIALS
trial_result
· 2022-09-29
Clinical Trial Update: Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer [Phase 3]
Summary
Phase 3 trial exploring umbilical cord blood mononuclear cell gel for refractory diabetic foot ulcer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University Third Hospital | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: UNKNOWN